DT Midstream Reports Strong Fourth Quarter 2022 Results; Raises 2023 Adjusted EBITDA Guidance
February 16, 2023 07:30 ET
|
DT Midstream, Inc.
Delivered 2022 results exceeding the high end of guidanceIncreased 2023 Adjusted EBITDA guidanceProvided 2024 Adjusted EBITDA early outlookIncreased dividend by 8% DETROIT, Feb. 16, 2023 (GLOBE...
Insilico Medicine to Present at 41st Annual J.P. Morgan Healthcare Meeting
November 29, 2022 09:00 ET
|
InSilico Medicine
New York, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine will present at the 41st Annual J.P. Morgan Healthcare Meeting happening Jan. 9-12, 2023 at the Westin St. Francis Hotel in San...
[Latest] Global Green Hydrogen Market Size/Share Worth USD 90 Billion by 2030 at a 55% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value, Analysis)
November 20, 2022 21:30 ET
|
Custom Market Insights
Sandy, Utah, USA, Nov. 20, 2022 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Green Hydrogen Market Size, Trends and Insights By Technology (Polymer...
Esperion Virtual Research & Development Day to Highlight Pipeline Programs and Scientific Focus
November 09, 2022 08:00 ET
|
Esperion Therapeutics, Inc.
– Event to Include Expert-Led Discussions on State of Cardiovascular Disease Treatments and Remaining Unmet Needs – – Esperion Leadership Will Provide Overview of its Investigational Pipeline,...
Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion
November 08, 2022 09:00 ET
|
InSilico Medicine
Abu Dhabi, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical stage artificial intelligence (AI)-driven drug discovery company, announced a multi-year, multi-target strategic research...
Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion
November 08, 2022 09:00 ET
|
InSilico Medicine
New York, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical stage artificial intelligence (AI)-driven drug discovery company, announced a multi-year, multi-target strategic research...
DT Midstream Closes on Purchase of Additional Ownership in Millennium Pipeline
October 07, 2022 16:15 ET
|
DT Midstream, Inc.
DETROIT, Oct. 07, 2022 (GLOBE NEWSWIRE) -- DT Midstream, Inc. (NYSE: DTM) today announced that it has closed on the $552 million purchase of an additional 26.25% ownership interest in Millennium...
DT Midstream Increases Ownership in Millennium Pipeline
September 29, 2022 07:30 ET
|
DT Midstream, Inc.
Premier, fully contracted pipeline with creditworthy customersImmediately accretive transactionConsistent with core investment thesis DETROIT, Sept. 29, 2022 (GLOBE NEWSWIRE) -- DT Midstream,...
SAB Biotherapeutics Advancing Pipeline and Expands into Treatment for C. Diff. as DoD Contract Winds Down
August 09, 2022 16:30 ET
|
SAB Biotherapeutics, Inc.
SIOUX FALLS, S.D., Aug. 09, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces...
DT Midstream Reports Strong Second Quarter 2022 Results; Announces Next Phase Haynesville Expansion
August 03, 2022 07:30 ET
|
DT Midstream, Inc.
Announces Phase 2 expansion of Haynesville systemReaffirms 2022 adjusted EBITDA guidance of $770 to $810 millionReaffirms 2023 adjusted EBITDA early outlook of $810 to $850 millionDeclares quarterly...